Back

Notification report

Full notification file


General information

Notification Number
B/NL/11/001

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
09/08/2011

Title of the Project
Ex vivo retroviral transduction of human T lymphocytes with melanoma-specific T cell receptor genes

Proposed period of release:
01/01/2011 to 01/10/2021

Name of the Institute(s) or Company(ies)
Netherlands Cancer Institute, Nederlands Kanker Instituut;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMPt been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
The GMO released into the environment are ex vivo retroviral transduced, autologous T cells that are administered intravenously to patients.
Used retrovirus for transduction: Gammaretrovirus, Moloney murine leukemia virus

Information relating to the recipient or parental organisms from wich the GMO is derived

Common Name	Genus	Species	Subspecies	Strain	Pathovar
MoMLV	Gammaretrovirus	Moloney murine leukemia virus	oncovirinae type C	dl587rev mutant

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known